Compare ImmunityBio Inc. Common Stock (IBRX) vs Marex Group Limited Ordinary Shares (MRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ImmunityBio Inc. Common Stock vs Marex Group Limited Ordinary Shares — how do they compare? ImmunityBio Inc. Common Stock trades at $10.71 (market cap $10.51B), while Marex Group Limited Ordinary Shares trades at $71.78 (market cap $5.12B). The key difference: ImmunityBio Inc. Common Stock is far larger — about 2.1× Marex Group Limited Ordinary Shares's market cap, and Marex Group Limited Ordinary Shares pays a 0.9% dividend while ImmunityBio Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold ImmunityBio Inc. Common Stock for 1 Days and Marex Group Limited Ordinary Shares for 1 Days on average.
| IBRX | MRX | |
|---|---|---|
Market Cap | $10.51B | $5.12B |
Volume | 10,445,785 | 647,370 |
Sector | Health | Financials |
52-Week High | $11.55 | $78.27 |
52-Week Low | $1.98 | $29.92 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $10.97B | $8.20B |
Dividend Yield | — | 0.9% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ImmunityBio Inc. Common Stock
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →About Marex Group Limited Ordinary Shares
Marex Group provides financial services across commodities, financial markets, and corporate clients. Its services include clearing, agency and execution, market making, hedging, and securities services.
Read more on MRX →
